These potential effects are mild compared to the common side effects of prescription GLP-1 medications, which include constipation , nausea, vomiting, headaches , fatigue , anxiety , and muscle pain
Boehringer Ingelheim, the manufacturer, has advanced survodutide into Phase 3 trials for both obesity and metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH)
How to Modify Your Schedule When extending a dose level, add one week at current dose before attempting the next increase
The program is FSA eligible, meaning you can use pre-tax health savings dollars to cover some or all of the cost
If the GLP-1/GIP/glucagon receptor class shows disease-modifying behaviour in OA rather than just mechanical pain relief from weight loss, it expands the scientific rationale for the compound and reinforces the argument that the triple-agonist mechanism is doing more than suppressing appetite
GLP1 treatments such as semaglutide (Wegovy) Dualagonists such as tirzepatide (Mounjaro) Noninjectable options such as orlistat